It is being billed by doctors as the best drug in weight management, compared to similar drugs available in the market ...

The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...

Vasudha Pharma Chem Limited and three employees are charged in DC court for illegally importing chemicals to produce fentanyl ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The confidence in India’s pharma manufacturing capabilities is also the courtesy of its robust infrastructure, adherence to ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Dr. Reddy’s Laboratories has received approval to conduct bioequivalence studies for semaglutide and plans to introduce the ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

A dozen stocks helped investors grow their money at least by one-fifth in the trading week ended March 21. GRSE, DB Realty, Nuvama Wealth, KEC International, BSE and Sun Pharma Advanced Research were ...